Vadodara: Alembic Pharma has announced the appointment of Jigr Shah as Head - Business Finance (Senior Management Personnel) ...

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug ...

Alembic Pharmaceuticals' Q4FY25 net profit declines 12% YoY to Rs 157 crore while revenue rises 17% to Rs 1,770 crore; India ...

An announcement from Alembic Limited ( (IN ... the production and distribution of pharmaceutical products and services. The company is headquartered in Vadodara, India, and is listed on major ...

Alembic Pharma reports 12% decline in net profit during Q4FY25: Our Bureau, New Delhi Wednesday, May 7, 2025, 15:45 Hrs [IST] Vadodara-based Alembic Pharmaceuticals has reported a ...

Alembic Pharmaceuticals Limited has commissioned a new manufacturing facility located at Pithampur, Dist: Dhar, Madhya Pradesh-454774 effective today, for manufacturing of formulations. Shares of ...

Alembic Pharmaceuticals has commissioned a new facility in Pithampur Madhya Pradesh for manufacturing formulations. The facility has been set up with an investment of around Rs.205 crore ...

Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor Tablets for heart attack and stroke prevention, with 90 mg tablets matching AstraZeneca's Brilinta. Estimated market size ...

Alembic Pharmaceuticals Ltd. announced its consolidated third quarter results ended March 31, 2025, which recorded good performance in core business operations. The company’s net sales grew 17% ...

Alembic Pharmaceuticals experienced a 12.1% dip in Q4 net profit, reaching Rs 156.63 crore, despite a 16.7% surge in revenue to Rs 1,769.64 crore. While India formulations and US revenue showed ...